INDIANAPOLIS / Jul 02, 2025 / Business Wire / Elevance Health (NYSE: ELV) will release second quarter 2025 financial results on July 17, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access... Read More

1Q 2025 operating revenue of $48.8 billion, up 15.4% from 1Q 2024 1Q 2025 adjusted operating gain 1 of $3.3 billion, up 4.1% from 1Q 2024 1Q 2025 diluted EPS 2 of $9.61; adjusted diluted EPS 1 of $11.97 Reaffirm FY 2025 adjusted diluted EPS 1 of $34.15 to $34.85 Returned $1.3 billion of capital to shareholders in 1Q 2025 INDIANAPOLIS / Apr 22, 2025 / Business Wire / Elevance Health, Inc. (NYSE: ELV) reported first quarter... Read More

INDIANAPOLIS / Mar 31, 2025 / Business Wire / Elevance Health (NYSE: ELV) will release first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access... Read More

4Q 2024 operating revenue of $45.0 billion; FY 2024 of $175.2 billion 4Q 2024 diluted EPS 1 of $1.81; adjusted diluted EPS 2 of $3.84 FY 2024 diluted EPS 1 of $25.68; adjusted diluted EPS 2 of $33.04 Projected FY 2025 GAAP diluted EPS 1 to be in the range of $30.40 to $31.10 Projected FY 2025 adjusted diluted EPS 2 to be in the range of $34.15 to $34.85 Quarterly dividend increased by 5% to $1.71 per share INDIANAPOLIS / Jan... Read More

INDIANAPOLIS / Jan 09, 2025 / Business Wire / Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:... Read More

INDIANAPOLIS / Nov 05, 2024 / Business Wire / Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on November 12, at 7:15 a.m. Pacific Standard Time (PST) / 10:15 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com... Read More

INDIANAPOLIS / Nov 04, 2024 / Business Wire / Elevance Health (NYSE: ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company’s growth initiatives and strengthen relationships within the investment community. He will also serve as a... Read More

3Q 2024 operating revenue of $44.7 billion 3Q 2024 adjusted operating gain 1 of $2.4 billion 3Q 2024 diluted EPS 2 of $4.36; adjusted diluted EPS 1 of $8.37 4Q 2024 dividend of $1.63 per share declared to shareholders INDIANAPOLIS / Oct 17, 2024 / Business Wire / Elevance Health, Inc. (NYSE: ELV) reported third quarter 2024 results. “We remain confident in the long-term earnings potential of our diverse businesses as we... Read More

INDIANAPOLIS / Oct 07, 2024 / Business Wire / Elevance Health (NYSE: ELV) will release third quarter 2024 financial results on October 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 –... Read More

Grant to support communities in recovery and rebuilding INDIANAPOLIS / Sep 30, 2024 / Business Wire / Elevance Health and its philanthropic arm, Elevance Health Foundation, are committed to strengthening the health of communities across the U.S. through community resiliency and disaster response efforts related to Hurricane Helene. Elevance Health and its Foundation are providing $500,000 in new grant funding to help... Read More

Whole Health Index is an industry-leading calculation for defining and measuring the most powerful drivers of individual and community health INDIANAPOLIS / Aug 12, 2024 / Business Wire / The Whole Health Index (WHI), created by Elevance Health, Inc. (NYSE: ELV) physicians, data scientists, and researchers, is a... Read More

2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain 1 of $2.8 billion 2Q 2024 diluted EPS 2 of $9.85, up 26%; adjusted diluted EPS 1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders INDIANAPOLIS / Jul 17, 2024 / Business Wire / Elevance Health, Inc. (NYSE: ELV) reported second quarter 2024 results. “Second quarter results reflect the power of our diversified business and... Read More

INDIANAPOLIS / Jul 08, 2024 / Business Wire / Elevance Health released its annual Impact Report, highlighting its continued evolution from a traditional health insurance benefits company to a diversified healthcare services organization. The report details significant achievements including the industry-leading Health Equity Accreditation Plus from the National Committee for Quality Assurance , support for Medicaid... Read More

INDIANAPOLIS / Jun 26, 2024 / Business Wire / Elevance Health (NYSE: ELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access... Read More

INDIANAPOLIS / May 30, 2024 / Business Wire / Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Goldman Sachs 45 th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link.... Read More

INDIANAPOLIS / May 20, 2024 / Business Wire / Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strategic Decisions Conference in New York City, on May 31 at 9:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may... Read More

1Q 2024 operating revenue of $42.3 billion, up 0.9% from 1Q 2023 1Q 2024 diluted EPS 1 of $9.59, up 15.5% from 1Q 2023 and adjusted diluted EPS 2 of $10.64, up 12.5% FY 2024 diluted EPS and adjusted diluted EPS guidance raised to greater than $34.05 and $37.20, respectively Launching strategic partnership to advance primary care and physician enablement INDIANAPOLIS / Apr 18, 2024 / Business Wire / Elevance Health, Inc.... Read More

Collaboration will leverage the strengths of three care provider entities that will come together to deliver value to consumers and employers across the healthcare journey INDIANAPOLIS / Apr 15, 2024 / Business Wire / Elevance Health, Inc. (NYSE: ELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care delivery, enhance the healthcare experience,... Read More

INDIANAPOLIS / Apr 03, 2024 / Business Wire / Elevance Health (NYSE: ELV) will release first quarter 2024 financial results on April 18, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access... Read More

Acquisition to enhance capabilities in multi-site infusion services, specialty pharmacy INDIANAPOLIS / Mar 11, 2024 / Business Wire / Elevance Health (NYSE: ELV) today announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies. Paragon Healthcare provides infusion services to patients through its omnichannel model of... Read More

INDIANAPOLIS / Feb 22, 2024 / Business Wire / Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the Cowen 44 th Annual Health Care Conference in Boston on March 5, at 2:50 p.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the... Read More

INDIANAPOLIS / Feb 22, 2024 / Business Wire / Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Barclays 26 th Annual Global Healthcare Conference in Miami, on March 14 at 9:30 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access... Read More

The JUST 100 is the only ranking that recognizes American corporate leadership on business issues prioritized by the public. INDIANAPOLIS / Feb 05, 2024 / Business Wire / Today JUST Capital along with CNBC released its annual JUST 100 list as part of its 2024 Rankings of America’s Most JUST Companies. Elevance Health (NYSE: ELV) ranked #8 overall and was recognized for the 6th consecutive year for its commitment to serving... Read More

4Q 2023 operating revenue of $42.5 billion, up 7.0% from 4Q 2022; FY 2023 operating revenue of $170 billion, up 9.3% from FY 2022 4Q 2023 GAAP diluted EPS 1 of $3.63, up 1.1% from 4Q 2022 and adjusted diluted EPS 2 of $5.62, up 15.2%; FY 2023 GAAP diluted EPS of $25.22, up 3.9% from FY 2022 and adjusted diluted EPS 2 of $33.14, up 16.2% Projected FY 2024 GAAP diluted EPS and adjusted diluted EPS 2 of greater than $34.29 and... Read More

INDIANAPOLIS / Jan 10, 2024 / Business Wire / Elevance Health (NYSE: ELV) will release fourth quarter and full year 2023 financial results on January 24, 2024 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:... Read More

Elevance Health gives eligible consumers no-cost access to customized suite of digital and virtual health tools through funding from the Affordable Connectivity Program LAS VEGAS / Jan 10, 2024 / Business Wire / Elevance Health announced at the Consumer Electronics Show 2024 that it will launch a first-of-its-kind program that will offer high-quality smartphones with unlimited data, talk, and texting service at no cost to... Read More

Paragon doubles revenues and increases the number of infusion centers by 400% during Peak Rock's ownership AUSTIN, Texas , Jan. 5, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private investment firm, announced today it has signed a definitive agreement for the sale of Paragon Healthcare, Inc. ("Paragon" or the "Company") to Elevance Healt h (NYSE: ELV). Paragon is a leading... Read More

Advances whole health by strengthening Elevance Health's capabilities in multi-site infusion services, specialty pharmacy INDIANAPOLIS / Jan 04, 2024 / Business Wire / Elevance Health (NYSE: ELV) today announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies. For more than 20 years, Paragon Healthcare has... Read More

Newly established accreditation earned by Elevance Health Medicaid plans that serve more than 10 million individuals nationwide Elevance Health’s approach to health equity prioritizes the needs of individuals who have been economically and socially marginalized and are at greatest risk of poor health INDIANAPOLIS / Dec 14, 2023 / Business Wire / Elevance Health, Inc. (NYSE: ELV) recently received the new Health Equity... Read More

Elevance Health is investing $1.42 million to help make IDD training mainstream in medical schools across the nation through the NICHE – Medical project. Currently, 73 percent of medical students graduate with no training on how to care for patients with IDD. Elevance Health funds for IDD curriculum have already been awarded to seven medical schools in 2023, and proposals for 2024 – 2025 academic year funding are currently... Read More

Third quarter GAAP net income was $5.45 per share, including net negative adjustment items of $3.54 per share. Adjusted net income was $8.99* per share. Operating gain, excluding adjustment items, grew 12.6% year-over-year to $2.5 billion. Operating cash flow was $2.6 billion. INDIANAPOLIS / Oct 18, 2023 / Business Wire / Elevance Health, Inc. (NYSE: ELV) reported third quarter 2023 results reflecting strong financial... Read More

INDIANAPOLIS / Oct 04, 2023 / Business Wire / Elevance Health (NYSE: ELV) will release third quarter 2023 financial results on October 18, 2023 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963... Read More

Plans support member preferences with affordable and simplified product offerings delivering choice and flexibility of benefits seniors value most Enhanced product offering and expansion into 91 new counties will empower more consumers to stay healthy, save money and provide even more options for convenient access to affordable healthcare Medicare-eligible individuals can enroll in a plan from October 15 – December 7... Read More

Indianapolis public school network received first ever fitness space, strength training clinics, and curriculum INDIANAPOLIS / Sep 15, 2023 / Business Wire / As part of their ongoing commitment to equity and providing support for women and women’s health, Elevance Health has partnered with national nonprofit Impact Fitness Foundation to create a fitness and movement space for K-12 public school network Victory College Prep... Read More

Mark Kaye named Executive Vice President, Chief Financial Officer INDIANAPOLIS / Aug 08, 2023 / Business Wire / Elevance Health (NYSE: ELV) announced today that John Gallina will retire from his role as executive vice president and CFO later this year. Mark Kaye has been named executive vice president and CFO and will serve as a member of the company’s executive leadership team, reporting directly to Gail K. Boudreaux,... Read More

New name reflects the company’s continued evolution to deliver whole health Wellpoint focused on improving the health of individuals and communities at all points of life No impact or changes to members’ health plan benefits, services and care provider network as a result of the new name INDIANAPOLIS / Jul 31, 2023 / Business Wire / Amerigroup, a subsidiary of Elevance Health serving Medicaid and Medicare enrollees, will... Read More

Second quarter GAAP net income was $7.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $9.04* per share. Operating revenue grew 12.7% year-over-year to $43.4 billion Operating gain grew 12.0% year-over-year to $2.6 billion Medical enrollment increased 938 thousand members year-over-year to 48.0 million members Third quarter 2023 dividend of $1.48 per share declared to... Read More

INDIANAPOLIS / Jun 28, 2023 / Business Wire / Elevance Health (NYSE: ELV) will release second quarter 2023 financial results on July 19, 2023, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963... Read More

INDIANAPOLIS / Jun 05, 2023 / Business Wire / Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the Goldman Sachs 44 th Annual Global Healthcare Conference in Dana Point, California on June 13 th at 10:00 a.m. Pacific Daylight Time (PDT)/1:00 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting... Read More

INDIANAPOLIS / May 18, 2023 / Business Wire / Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the Bernstein 39 th Annual Strategic Decisions Conference in New York City on June 1, at 8:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You... Read More

INDIANAPOLIS / May 05, 2023 / Business Wire / Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City on May 17, at 8:00 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. Following... Read More

First quarter GAAP net income was $8.30 per share, including net negative adjustment items of $1.16 per share. Adjusted net income was $9.46* per share. Operating revenue grew 10.6% year-over-year to $41.9 billion Operating gain grew 16.6% year-over-year to $2.8 billion Medical enrollment increased 1.3 million members year-over-year to 48.1 million members Second quarter 2023 dividend of $1.48 per share declared to... Read More

INDIANAPOLIS / Apr 05, 2023 / Business Wire / Elevance Health (NYSE: ELV) will release first quarter 2023 financial results on April 19, 2023, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963... Read More

Report Highlights How Partnerships with Care Providers are Measurably Improving Whole Health INDIANAPOLIS / Mar 30, 2023 / Business Wire / In a new report issued by Elevance Health, Inc. (NYSE: ELV) the company highlights its continued efforts to advance health beyond healthcare by partnering with the nation’s care providers. The Advancing Health Together: Progress Report details how by working together to contract for... Read More

INDIANAPOLIS / Mar 09, 2023 / Business Wire / Elevance Health (NYSE: ELV) will host an Investor Conference with analysts and investors on March 23, 2023 in New York City. The event will feature presentations and Q&A sessions with the company’s senior leadership team. The conference will be webcast live beginning at 8:00 a.m. ET and will conclude by 12:00 p.m. ET. All interested parties are invited to register and access the... Read More

INDIANAPOLIS / Mar 03, 2023 / Business Wire / Individuals who experience long COVID are at increased risk for a wide range of adverse cardiovascular and pulmonary conditions and mortality, according to a new study published in JAMA Health Forum. The study , led by researchers at the Elevance Health Public Policy Institute, found substantially higher mortality rates for individuals with long COVID than what had been found in... Read More

INDIANAPOLIS / Feb 15, 2023 / Business Wire / Elevance Health (NYSE: ELV) today announced the closing of its acquisition of BioPlus, a comprehensive specialty pharmacy subsidiary of CarepathRx, a portfolio company of Nautic Partners. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, hepatitis C, autoimmune diseases,... Read More

INDIANAPOLIS / Jan 25, 2023 / Business Wire / Elevance Health, Inc. (NYSE: ELV) announced today that for the six-month interest period commencing on October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 (the “Debentures”) will accrue contingent interest at a rate of 0.50% per annum of the average trading price of a Debenture for the ten consecutive trading days ended October 14, 2022. Contingent interest, which... Read More

Fourth quarter and full year GAAP net income was $3.93 and $24.81 per share Fourth quarter and full year adjusted net income was $5.23* and $29.07* per share Full year operating revenue grew 13.7% year-over-year to $156 billion Full year operating gain grew 12.9% year-over-year to $8.5 billion Medical enrollment increased 2.2 million members year-over-year to 47.5 million members Quarterly dividend increased by 16% to $1.48... Read More

INDIANAPOLIS / Jan 23, 2023 / Business Wire / Elevance Health, Inc. ( NYSE: ELV) and Blue Cross and Blue Shield of Louisiana announced today that the companies have entered into a definitive agreement through which Elevance Health agrees to acquire Blue Cross and Blue Shield of Louisiana (BCBSLA). BCBSLA will join Elevance Health’s affiliated Anthem Blue Cross Blue Shield family of brands. This acquisition will unite two... Read More

Elevance Health (NYSE: ELV) will release fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 (Domestic) 312-470-0178 (International)... Read More

INDIANAPOLIS--( BUSINESS WIRE )-- Elevance Health (NYSE: ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners , to acquire BioPlus, a comprehensive specialty pharmacy. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, hepatitis C, autoimmune diseases, and... Read More